SCHEMBL1250698

SCHEMBL1250698

C=CCOC(=O)CNC1CNC(C(=O)O)C1

nearest known ligand 0.36

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.36
GAA P10253 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP2D6 P10635 1/20 0.36
ALOX15 P16050 1/20 0.36
CYP2C19 P33261 1/20 0.36
SLC1A3 P43003 1/20 0.36
SLC1A2 P43004 1/20 0.36
SLC1A1 P43005 1/20 0.36
DPP4 P27487 1/20 0.34
ARG1 P05089 1/20 0.33
DPP8 Q6V1X1 2/20 0.32
DPP9 Q86TI2 2/20 0.32
DPP7 Q9UHL4 2/20 0.32
EPHX2 P34913 1/20 0.32
PKM P14618 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
TSHR P16473 1/20 0.31
CHRM1 P11229 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1250701 1.00 ALDH1A1 (0.36) ALDH1A1GAACYP1A2CYP2D6ALOX15
SCHEMBL1250695 1.00 ALDH1A1 (0.36) ALDH1A1GAACYP1A2CYP2D6ALOX15
SCHEMBL2518933 0.81 DPP8 (0.41) ALDH1A1DPP4DPP8DPP9DPP7
SCHEMBL6672005 0.81 CYP1A2 (0.38) ALDH1A1GAACYP1A2CYP2D6ALOX15
SCHEMBL3902694 0.81 CYP1A2 (0.38) ALDH1A1GAACYP1A2CYP2D6ALOX15
SCHEMBL3898562 0.81 CYP1A2 (0.38) ALDH1A1GAACYP1A2CYP2D6ALOX15
SCHEMBL6672006 0.81 CYP1A2 (0.38) ALDH1A1GAACYP1A2CYP2D6ALOX15
Hydrochloric Acid SCHEMBL5678592 0.80 TSHR (0.41) ALDH1A1DPP4DPP8DPP9DPP7
Hydrochloric Acid SCHEMBL5678584 0.80 TSHR (0.41) ALDH1A1DPP4DPP8DPP9DPP7
Hydrochloric Acid SCHEMBL5678582 0.80 TSHR (0.41) ALDH1A1DPP4DPP8DPP9DPP7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2279737-B1 Heterocyclic compounds that are active as beta lactamase inhibitors NOVEXEL (FR) 2012-10-31 EP disclosed
EP-2279737-A1 Heterocyclic compounds that are active as beta lactamase inhibitors NOVEXEL (FR) 2011-02-02 EP disclosed
EP-1480644-B1 NOVEL HETEROCYCLIC COMPOUNDS WHICH ARE ACTIVE AS INHIBITORS OF BETA+LACTAMASES NOVEXEL (FR) 2010-10-13 EP disclosed
EP-1480644-A2 NOVEL HETEROCYCLIC COMPOUNDS WHICH ARE ACTIVE AS INHIBITORS OF BETA+LACTAMASES Aventis Pharma S.A. (FR) 2004-12-01 EP disclosed
EP-1307457-B1 AZABICYCLIC COMPOUNDS, PREPARATION THEREOF AND USE AS MEDICINES, IN PARTICULAR AS ANTIBACTERIAL AGENTS AVENTIS PHARMA SA (FR) 2004-04-07 EP disclosed
WO-2003063864-A2 HETEROCYCLIC COMPOUNDS WHICH ARE ACTIVE AS INHIBITORS OF BETA LACTAMASES AVENTIS PHARMA S.A. (FR) 2003-08-07 WO disclosed